Advertisement

Awareness and Beliefs About Cervical Cancer, the HPV Vaccine, and Cervical Cancer Screening Among Ghanaian Women with Diverse Education Levels

  • Michelle S. Williams
  • Ernest Kenu
  • Augustine Adanu
  • Ruth Angela Yalley
  • Nicholas Kwaku Lawoe
  • Akpanga Seyram Dotse
  • Rita Fosuah Adu
  • Kevin Fontaine
Article

Abstract

Cervical cancer is the leading cause of cancer death among women in Ghana. Cost-effective tools for the primary and secondary prevention of cervical cancer, such as the Pap test, the HPV DNA test, and the HPV vaccine, are available in hospitals and clinics throughout Ghana. However, participation in cervical cancer prevention behaviors is low among Ghanaian women. Our objective was to determine if there were significant differences in cervical cancer awareness and stigmatizing beliefs about women with cervical cancer between Ghanaian women of different education levels. We surveyed 288 Ghanaian women who were at least 18 years old. Data on the participants’ demographic characteristics, awareness of cervical cancer, cervical cancer screening, and the HPV vaccine, beliefs about cervical cancer screening, and stigmatizing beliefs about women with cervical cancer was collected. Chi-square tests for independence and Fisher’s exact test of independence were preformed to determine if education level was associated with those factors. Participation in cervical cancer screening and uptake of the HPV vaccine was significantly lower among women with less than a senior high school education. Awareness about cervical cancer, cervical cancer screening, and the HPV vaccine was lower among women with less education. Women with lower levels of education were more likely to agree with the negative statements about cervical cancer screening and stigmatizing beliefs about women with cervical cancer. Cervical cancer education interventions that are tailored for Ghanaian women with different educational levels are needed to increase awareness of and participation in cervical cancer prevention strategies.

Keywords

Cervical cancer prevention Ghana Women’s Health 

Notes

Acknowledgements

Special thanks to the women who participated in this study. Sincere appreciation goes to Dorothy Kelly for supporting this study. Thank you to Chee Paul Linn for his assistance with the data analysis and Drs. Bettina Beech and Derek Griffith for their review of the manuscript. This project was supported by a Career Enhancement Award from the University of Alabama at Birmingham Office of Postdoctoral Education. The content is solely the responsibility of the authors and does not necessarily represent the official views of the author’s institutions.

Compliance with Ethical Standards

Approval to conduct this study was provided by the Institutional Review Boards at the University of Alabama at Birmingham (UAB) in Birmingham (X150218005), and the Noguchi Memorial Institute for Medical Research in Accra (077/14-15). The scientific protocol was approved by the UAB Comprehensive Cancer Center Protocol Review Committee.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Bruni L, Barrionuevo-Rosas L, Albero G et al (2017) Human papillomavirus and related diseases in Ghana. Summary report. In: ICO information centre on HPV and cancer (HPV information centre)Google Scholar
  2. 2.
    Agyei-Mensah S, de-Graft Aikins A (2010) Epidemiological transition and the double burden of disease in Accra, Ghana. J Urban Health 87(5):879–897CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    de-Graft Aikins A, Addo J, Ofei F, Bosu W, Agyemang C (2012) Ghana’s burden of chronic non-communicable diseases: future directions in research, practice and policy. Ghana Med J 46:1–3PubMedPubMedCentralGoogle Scholar
  4. 4.
    Forman D, Bray F, Brewster DH et al (eds) (2014) Cancer incidence in five continents. International Agency for Research on Cancer, LyonGoogle Scholar
  5. 5.
    Jeronimo J, Bansil P, Lim J et al (2014) A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer. Int J Gynecol Cancer 24:576–585CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Quentin W, Adu-Sarkodie Y, Terris-Prestholt F, Legood R, Opoku BK, Mayaud P (2011) Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale. Tropical Med Int Health 16:379–389CrossRefGoogle Scholar
  7. 7.
    Campos NG, Sharma M, Clark A, Kim JJ, Resch SC (2016) Resources required for cervical cancer prevention in low- and middle-income countries. PLoS One 11:e0164000CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Mvundura M, Tsu V (2014) Estimating the costs of cervical cancer screening in high-burden Sub-Saharan African countries. Int J Gynecol Obstet 126:151–155CrossRefGoogle Scholar
  9. 9.
    Gakidou E, Nordhagen S, Obermeyer Z (2008) Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 5:e132CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Blumenthal PD, Gaffikin L, Deganus S et al (2007) Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol 196:407 e1–8 discussion 407 e8–9CrossRefGoogle Scholar
  11. 11.
    Bosu WK (2012) A Comprehensive review of the policy and programmatic response to chronic non-communicable disease in Ghana. Ghana Med J 46:69–78PubMedPubMedCentralGoogle Scholar
  12. 12.
    Awua AK, Sackey ST, Osei YD, Asmah RH, Wiredu EK (2016) Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana. Infect Agents Cancer 11:4CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Handlogten KS, Molitor RJ, Roeker LE, Narla NP, Bachman MJ, Quayson S, Owusu-Afriyie O, Adjei E, Ankobea F, Clayton A, Roberts L, MacLaughlin K, Ansong D (2014) Cervical cancer screening in Ghana, West Africa: prevalence of abnormal cytology and challenges for expanding screening. Int J Gynecol Pathol 33(2):197–202CrossRefPubMedGoogle Scholar
  14. 14.
    Laryea DO, Awuah B, Amoako YA, Osei-Bonsu E, Dogbe J, Larsen-Reindorf R, Ansong D, Yeboah-Awudzi K, Oppong JK, Konney TO, Boadu KO, Nguah SB, Titiloye NA, Frimpong NO, Awittor FK, Martin IK (2014) Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry. BMC Cancer 14:362CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Denny L, Hendricks B, Gordon C, Thomas F, Hezareh M, Dobbelaere K, Durand C, Hervé C, Descamps D (2013) Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study. Vaccine 31:5745–5753CrossRefPubMedGoogle Scholar
  16. 16.
    Morhason-Bello IO, Odedina F, Rebbeck TR, Harford J, Dangou JM, Denny L, Adewole IF (2013) Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol 14(4):e142–e151CrossRefPubMedGoogle Scholar
  17. 17.
    (2014) Comprehensive cervical cancer control: a guide to essential practice. In. second ed. Geneva: World Health OrganizationGoogle Scholar
  18. 18.
    Kwan TTC, Lo SST, Tam K-F, Chan KKL, Ngan HYS (2012) Assessment of knowledge and stigmatizing attitudes related to human papillomavirus among Hong Kong Chinese healthcare providers. Int J Gynecol Obstet 116:52–56CrossRefGoogle Scholar
  19. 19.
    Williams MS, Kuffour G, Ekuadzi E et al (2013) Assessment of psychological barriers to cervical cancer screening among women in Kumasi, Ghana using a mixed methods approach. Afr Health Sci 13(4):1048–1055Google Scholar
  20. 20.
    Williams MS (2014) A qualitative assessment of the social cultural factors that influence cervical cancer screening behaviors and the health communication preferences of women in Kumasi, Ghana. J Cancer Educ 29(3):555–562CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Adanu RM (2002) Cervical cancer knowledge and screening in Accra, Ghana. J Women's Health Gend Based Med 11:487–488CrossRefGoogle Scholar
  22. 22.
    Abotchie PN, Shokar NK (2009) Cervical cancer screening among college students in Ghana: knowledge and health beliefs. Int J Gynecol Cancer 19(3):412–416CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Ebu NI, Mupepi SC, Siakwa MP, Sampselle CM (2015) Knowledge, practice, and barriers toward cervical cancer screening in Elmina, Southern Ghana. Int J Women’s Health 7:31–39Google Scholar
  24. 24.
    Coleman MA, Levison J, Sangi-Haghpeykar H (2011) HPV vaccine acceptability in Ghana, West Africa. Vaccine 29:3945–3950CrossRefPubMedGoogle Scholar
  25. 25.
    Gavi (2013) Annual progress report 2012. In: GaviGoogle Scholar
  26. 26.
    Goldie SJ, O’Shea M, Campos NG, Diaz M, Sweet S, Kim SY (2008) Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine 26:4080–4093CrossRefPubMedGoogle Scholar
  27. 27.
    Edwin AK (2010) Is routine human papillomavirus vaccination an option for Ghana? Ghana Med J 44:70–75PubMedPubMedCentralGoogle Scholar
  28. 28.
    Education and Literacy Statistics for Ghana. http://uis.unesco.org/en/country/GH

Copyright information

© American Association for Cancer Education 2018

Authors and Affiliations

  1. 1.University of Mississippi Medical CenterJacksonUSA
  2. 2.University of GhanaAccraGhana
  3. 3.Korle Bu Teaching HospitalAccraGhana
  4. 4.University of Alabama at BirminghamBirminghamUSA

Personalised recommendations